Ashish Khanna to Vasoconstrictor Agents
This is a "connection" page, showing publications Ashish Khanna has written about Vasoconstrictor Agents.
Connection Strength
5.619
-
Wieruszewski PM, Khanna AK. Early Multimodal Vasopressors-Are We Ready for It? Crit Care Med. 2022 04 01; 50(4):705-708.
Score: 0.821
-
Palm NM, Vallabhajosyula S, Chen A, Lam SW, Weister TJ, Kashani K, Naylor D, Khanna AK. Timing of resumption of beta-blockers after discontinuation of vasopressors is not associated with post-operative atrial fibrillation in critically ill patients recovering from non-cardiac surgery: A retrospective cohort analysis. J Crit Care. 2020 12; 60:177-182.
Score: 0.733
-
Wakefield BJ, Busse LW, Khanna AK. Angiotensin II in Vasodilatory Shock. Crit Care Clin. 2019 Apr; 35(2):229-245.
Score: 0.658
-
Wakefield BJ, Sacha GL, Khanna AK. Vasodilatory shock in the ICU and the role of angiotensin II. Curr Opin Crit Care. 2018 08; 24(4):277-285.
Score: 0.636
-
Khanna A, English SW, Wang XS, Ham K, Tumlin J, Szerlip H, Busse LW, Altaweel L, Albertson TE, Mackey C, McCurdy MT, Boldt DW, Chock S, Young PJ, Krell K, Wunderink RG, Ostermann M, Murugan R, Gong MN, Panwar R, Hästbacka J, Favory R, Venkatesh B, Thompson BT, Bellomo R, Jensen J, Kroll S, Chawla LS, Tidmarsh GF, Deane AM. Angiotensin II for the Treatment of Vasodilatory Shock. N Engl J Med. 2017 08 03; 377(5):419-430.
Score: 0.586
-
Kotani Y, Landoni G, Belletti A, Khanna AK. Response to: norepinephrine formulation for equivalent vasopressive score. Crit Care. 2023 Mar 28; 27(1):125.
Score: 0.220
-
Kotani Y, Di Gioia A, Landoni G, Belletti A, Khanna AK. An updated "norepinephrine equivalent" score in intensive care as a marker of shock severity. Crit Care. 2023 Jan 20; 27(1):29.
Score: 0.217
-
Wieruszewski PM, Khanna AK. Vasopressor Choice and Timing in Vasodilatory Shock. Crit Care. 2022 03 22; 26(1):76.
Score: 0.205
-
Bellomo R, Forni LG, Busse LW, McCurdy MT, Ham KR, Boldt DW, Hästbacka J, Khanna AK, Albertson TE, Tumlin J, Storey K, Handisides D, Tidmarsh GF, Chawla LS, Ostermann M. Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical Trial. Am J Respir Crit Care Med. 2020 11 01; 202(9):1253-1261.
Score: 0.186
-
Font MD, Thyagarajan B, Khanna AK. Sepsis and Septic Shock - Basics of diagnosis, pathophysiology and clinical decision making. Med Clin North Am. 2020 Jul; 104(4):573-585.
Score: 0.180
-
Lam SW, Barreto EF, Scott R, Kashani KB, Khanna AK, Bauer SR. Cost-effectiveness of second-line vasopressors for the treatment of septic shock. J Crit Care. 2020 02; 55:48-55.
Score: 0.173
-
Venkatesh B, Khanna AK, Cohen J. Less is more: catecholamine-sparing strategies in septic shock. Intensive Care Med. 2019 12; 45(12):1810-1812.
Score: 0.172
-
Abril MK, Khanna AK, Kroll S, McNamara C, Handisides D, Busse LW. Regional differences in the treatment of refractory vasodilatory shock using Angiotensin II in High Output Shock (ATHOS-3) data. J Crit Care. 2019 04; 50:188-194.
Score: 0.163
-
Khanna AK. Searching for better outcomes in septic shock trials. J Crit Care. 2018 10; 47:331-332.
Score: 0.157
-
Jentzer JC, Vallabhajosyula S, Khanna AK, Chawla LS, Busse LW, Kashani KB. Management of Refractory Vasodilatory Shock. Chest. 2018 08; 154(2):416-426.
Score: 0.153
-
Khanna A, Ostermann M, Bellomo R. Angiotensin II for the Treatment of Vasodilatory Shock. N Engl J Med. 2017 12 28; 377(26):2604.
Score: 0.153
-
Wieruszewski PM, Bellomo R, Busse LW, Ham KR, Zarbock A, Khanna AK, Deane AM, Ostermann M, Wunderink RG, Boldt DW, Kroll S, Greenfeld CR, Hodges T, Chow JH. Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trial. Crit Care. 2023 May 05; 27(1):175.
Score: 0.055
-
Bansal M, Mehta A, Wieruszewski PM, Belford PM, Zhao DX, Khanna AK, Vallabhajosyula S. Efficacy and safety of angiotensin II in cardiogenic shock: A systematic review. Am J Emerg Med. 2023 Apr; 66:124-128.
Score: 0.054
-
Dugar S, Khanna AK, Duggal A. Is Early Vasopressor Safe in Septic Shock? Crit Care Med. 2022 Jun 01; 50(6):e599-e600.
Score: 0.052
-
Klijian A, Khanna AK, Reddy VS, Friedman B, Ortoleva J, Evans AS, Panwar R, Kroll S, Greenfeld CR, Chatterjee S. Treatment With Angiotensin II Is Associated With Rapid Blood Pressure Response and Vasopressor Sparing in Patients With Vasoplegia After Cardiac Surgery: A Post-Hoc Analysis of Angiotensin II for the Treatment of High-Output Shock (ATHOS-3) Study. J Cardiothorac Vasc Anesth. 2021 Jan; 35(1):51-58.
Score: 0.046